Impact of Pain and Functional Impairment In US Adult People with Hemophilia (PWH)
Results from Retest Population in the Pain Functional Impairment and Quality of Life (P-FIQ) Study
ISTH 2015 (Toronto, June 20-25) Results from the retest population in the Pain, Functional Impairment, and Quality of life (P-FIQ) study were presented as a poster at the International Society on Thrombosis and Hemostasis (ISTH) 2015 Meeting. The study reported on 164 patients with hemophilia who completed the P-FIQ study including repeating patient surveys at the beginning and end of a routine comprehensive care visit to assess reliability. Pain and its impact on daily activities and quality of life were noted in each patient-reported outcome survey tool with 43.3% of US adult people with hemophilia reporting having experienced moderate/severe/extreme pain or discomfort.
The P-FIQ Study (NCT01988532) was sponsored by Novo Nordisk Inc.